James Frederick is a practicing Physician Associate (PA-C, MMSc) who studied at Yale University. He also has a bachelor’s degree in creative writing and English Literature from the University of Colorado. He specializes in writing medical content that is approachable, readable and enjoyable. He has a strong background in research, physiology, pharmacotherapy, emergency medicine and critical care medicine. In his free time he enjoys spending my time camping and traveling with his wife and dog.
Veracyte recently announced that results from a study supporting the development of the Envisia Genomic Classifier, a genomic test used to improve the diagnosis of idiopathic pulmonary fibrosis (IPF), have been ... Read more
A new European study suggests that a large percentage of patients (94 percent in this study) suffering from severe asthma still struggle with the burden of uncontrolled disease. The data, ... Read more
Lung Therapeutics, which specializes in therapies for fibrosis, lung injury and lung disease, announced that it has raised $14.3 million in Series B financing. The funding will support ongoing clinical trials in Australia ... Read more
A new European study indicates the financial burden and mortality associated with non-tuberculosis mycobacterium pulmonary disease (NTM-PD) is higher than previously suspected. The study reporting the findings, “Burden of non-tuberculous ... Read more